STOCK TITAN

[Form 4] ARAMARK Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Aramark (ARMK) Form 4: James J. Tarangelo, SVP and Chief Financial Officer, reported an acquisition on 08/20/2025 of 60.475 common stock units described as dividend equivalent rights tied to restricted stock units; the units were recorded at a $0 price because they represent accrued dividend equivalents rather than a cash purchase. After this transaction Tarangelo beneficially owns 48,454.846 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The filing notes the dividend equivalents vest on the same schedule as the underlying restricted stock awards.

Aramark (ARMK) Modulo 4: James J. Tarangelo, SVP e Chief Financial Officer, ha dichiarato l'acquisizione in data 20/08/2025 di 60.475 unità di azioni ordinarie descritte come diritti equivalenti a dividendi collegati a restricted stock unit; le unità sono state registrate a un prezzo di $0 poiché rappresentano dividendi maturati e non un acquisto in contanti. Dopo questa operazione Tarangelo detiene beneficiariamente 48.454.846 azioni. Il documento è stato firmato da un procuratore il 21/08/2025. Nel filing si precisa che gli equivalenti di dividendo maturano secondo lo stesso calendario delle restricted stock sottostanti.

Aramark (ARMK) Formulario 4: James J. Tarangelo, SVP y Director Financiero, reportó una adquisición el 20/08/2025 de 60.475 unidades de acciones ordinarias descritas como derechos equivalentes a dividendos vinculados a unidades de acciones restringidas; las unidades se registraron a un precio de $0 porque representan dividendos devengados y no una compra en efectivo. Tras esta transacción Tarangelo posee beneficiariamente 48.454.846 acciones. El documento fue firmado por un apoderado el 21/08/2025. El informe indica que los equivalentes de dividendos se consolidan según el mismo calendario de adquisición que los premios de acciones restringidas subyacentes.

Aramark (ARMK) Form 4: James J. Tarangelo, SVP 겸 최고재무책임자(CFO)는 2025-08-20에 60.475의 보통주 단위를 인수했다고 보고했습니다. 해당 단위는 제한주식단위(RSU)에 연동된 배당금 등가권으로 설명되며, 현금 매수로 인한 것이 아니라 발생한 배당금 등가액을 나타내므로 $0 가격으로 기록되었습니다. 이 거래 이후 Tarangelo는 실질적으로 48.454.846주를 보유하게 됩니다. 해당 신고서는 2025-08-21에 대리인이 서명했습니다. 신고서에는 배당금 등가권이 기초 제한주식 수상과 동일한 베스팅 일정에 따라 베스트된다고 명시되어 있습니다.

Aramark (ARMK) Formulaire 4 : James J. Tarangelo, SVP et directeur financier, a déclaré une acquisition le 20/08/2025 de 60.475 unités d'actions ordinaires décrites comme des droits équivalents de dividendes liés à des restricted stock units ; ces unités ont été enregistrées à un prix de $0 car elles représentent des équivalents de dividendes accumulés et non un achat en espèces. Après cette opération, Tarangelo détient à titre bénéficiaire 48.454.846 actions. le document a été signé par un mandataire le 21/08/2025. Le dépôt précise que les équivalents de dividendes acquièrent selon le même calendrier que les awards d'actions restreintes sous-jacents.

Aramark (ARMK) Formular 4: James J. Tarangelo, SVP und Chief Financial Officer, meldete am 20.08.2025 den Erwerb von 60.475 Stammaktien-Einheiten, die als Dividendenäquivalente im Zusammenhang mit Restricted Stock Units beschrieben werden; die Einheiten wurden mit einem Preis von $0 erfasst, da sie aufgelaufene Dividendenäquivalente und keinen Barkauf darstellen. Nach dieser Transaktion besitzt Tarangelo wirtschaftlich 48.454.846 Aktien. Die Einreichung wurde am 21.08.2025 von einem Bevollmächtigten unterschrieben. In der Meldung wird angegeben, dass die Dividendenäquivalente nach demselben Zeitplan vesten wie die zugrunde liegenden Restricted Stock Awards.

Positive
  • Reported acquisition increases executive beneficial ownership to 48,454.846 shares
  • Disclosure aligns with standard Section 16 reporting and describes vesting terms for dividend equivalents
Negative
  • None.

Insights

TL;DR: Routine insider accrual increases executive ownership slightly via dividend equivalent settlement; immaterial for valuation.

The reported acquisition of 60.475 dividend-equivalent shares at $0 is a non-cash, compensation-related adjustment tied to existing restricted stock units. This raises the reporting person’s beneficial ownership to 48,454.846 shares, a small incremental change relative to typical executive holdings at large-cap companies. There is no cash outlay and no change to company capital structure. For investors, this is a standard compensation vesting event and not a material corporate development.

TL;DR: Compensation-related vesting disclosed properly; governance procedures appear followed.

The Form 4 discloses dividend equivalent rights credited to the CFO that vest on the same schedule as underlying restricted stock units, suggesting standard award terms and consistent reporting. The filing is timely and signed by an attorney-in-fact, indicating adherence to Section 16 reporting practices. There is no indication of accelerated vesting, related-party transactions, or other governance concerns based on this disclosure alone.

Aramark (ARMK) Modulo 4: James J. Tarangelo, SVP e Chief Financial Officer, ha dichiarato l'acquisizione in data 20/08/2025 di 60.475 unità di azioni ordinarie descritte come diritti equivalenti a dividendi collegati a restricted stock unit; le unità sono state registrate a un prezzo di $0 poiché rappresentano dividendi maturati e non un acquisto in contanti. Dopo questa operazione Tarangelo detiene beneficiariamente 48.454.846 azioni. Il documento è stato firmato da un procuratore il 21/08/2025. Nel filing si precisa che gli equivalenti di dividendo maturano secondo lo stesso calendario delle restricted stock sottostanti.

Aramark (ARMK) Formulario 4: James J. Tarangelo, SVP y Director Financiero, reportó una adquisición el 20/08/2025 de 60.475 unidades de acciones ordinarias descritas como derechos equivalentes a dividendos vinculados a unidades de acciones restringidas; las unidades se registraron a un precio de $0 porque representan dividendos devengados y no una compra en efectivo. Tras esta transacción Tarangelo posee beneficiariamente 48.454.846 acciones. El documento fue firmado por un apoderado el 21/08/2025. El informe indica que los equivalentes de dividendos se consolidan según el mismo calendario de adquisición que los premios de acciones restringidas subyacentes.

Aramark (ARMK) Form 4: James J. Tarangelo, SVP 겸 최고재무책임자(CFO)는 2025-08-20에 60.475의 보통주 단위를 인수했다고 보고했습니다. 해당 단위는 제한주식단위(RSU)에 연동된 배당금 등가권으로 설명되며, 현금 매수로 인한 것이 아니라 발생한 배당금 등가액을 나타내므로 $0 가격으로 기록되었습니다. 이 거래 이후 Tarangelo는 실질적으로 48.454.846주를 보유하게 됩니다. 해당 신고서는 2025-08-21에 대리인이 서명했습니다. 신고서에는 배당금 등가권이 기초 제한주식 수상과 동일한 베스팅 일정에 따라 베스트된다고 명시되어 있습니다.

Aramark (ARMK) Formulaire 4 : James J. Tarangelo, SVP et directeur financier, a déclaré une acquisition le 20/08/2025 de 60.475 unités d'actions ordinaires décrites comme des droits équivalents de dividendes liés à des restricted stock units ; ces unités ont été enregistrées à un prix de $0 car elles représentent des équivalents de dividendes accumulés et non un achat en espèces. Après cette opération, Tarangelo détient à titre bénéficiaire 48.454.846 actions. le document a été signé par un mandataire le 21/08/2025. Le dépôt précise que les équivalents de dividendes acquièrent selon le même calendrier que les awards d'actions restreintes sous-jacents.

Aramark (ARMK) Formular 4: James J. Tarangelo, SVP und Chief Financial Officer, meldete am 20.08.2025 den Erwerb von 60.475 Stammaktien-Einheiten, die als Dividendenäquivalente im Zusammenhang mit Restricted Stock Units beschrieben werden; die Einheiten wurden mit einem Preis von $0 erfasst, da sie aufgelaufene Dividendenäquivalente und keinen Barkauf darstellen. Nach dieser Transaktion besitzt Tarangelo wirtschaftlich 48.454.846 Aktien. Die Einreichung wurde am 21.08.2025 von einem Bevollmächtigten unterschrieben. In der Meldung wird angegeben, dass die Dividendenäquivalente nach demselben Zeitplan vesten wie die zugrunde liegenden Restricted Stock Awards.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Tarangelo James J.

(Last) (First) (Middle)
2400 MARKET STREET

(Street)
PHILADELPHIA PA 19103

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SVP and CFO
3. Date of Earliest Transaction (Month/Day/Year)
08/20/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 08/20/2025 A 60.475(1) A $0 48,454.846 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Represents dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the reporting person on restricted stock units. These dividend equivalent rights vest on the same schedules as the underlying awards.
Remarks:
/s/ Ryan S. Spengler, as Attorney-in-fact 08/21/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did James J. Tarangelo report on Form 4 for ARMK?

He reported an acquisition of 60.475 dividend-equivalent common stock units on 08/20/2025 tied to restricted stock units.

Did the reported ARMK transaction involve a cash purchase?

No. The filing shows a $0 price because these are dividend equivalent rights credited on restricted stock units, not a cash purchase.

How many Aramark shares does the reporting person beneficially own after the transaction?

The Form 4 reports 48,454.846 shares beneficially owned following the reported transaction.

When did the reported transaction occur and when was the Form 4 signed?

The transaction date is 08/20/2025 and the Form 4 was signed by an attorney-in-fact on 08/21/2025.

What is the nature of the securities acquired in this Form 4?

They are dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.
Aramark US

NYSE:ARMK

ARMK Rankings

ARMK Latest News

ARMK Latest SEC Filings

ARMK Stock Data

10.53B
261.16M
0.62%
99.69%
2.74%
Specialty Business Services
Retail-eating Places
Link
United States
PHILADELPHIA